Eurasia Energy Limited (OTCPK:EUENF) entered into a share purchase agreement to acquire Rhino Biotech, Inc. for $22.5 million on September 3, 2021. As a part of consideration, Eurasia Energy Limited will issue 500 million shares at a price of $0.02 per share. Transaction is subject to customary closing conditions. Brad Haneberg of Haneberg Hurlbert, PLC acted as legal advisor to Eurasia Energy Limited. Eric Liebman of Moye White LLP acted as legal advisor to Rhino Biotech, Inc.

Rhino Biotech Limited (OTCPK:RBRX.F) completed the acquisition of Rhino Biotech, Inc. on November 3, 2021. Rhino Biotech Limited issued the consideration shares on November 3, 2021.